Azabicyclic compounds are central nervous system active agents

Details Azabicyclic compounds are central nervous system active agents Azabicyclic compounds are central nervous system active agents

2006-11-14

2006-11-14

Saeed, Kamal A. (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S422000, C546S276700, C548S517000

Reexamination Certificate

active

07135484

ABSTRACT:
Compounds of formula (I)are novel CNS active agents that are useful for treating pain and for treating other disorders associated with the cholinergic system.

REFERENCES:
patent: 2858314 (1958-10-01), Georgian
patent: 5929087 (1999-07-01), Efange et al.
patent: 6489328 (2002-12-01), Snow et al.
patent: 6844435 (2005-01-01), Snow et al.
patent: 2002/0094989 (2002-07-01), Hale et al.
patent: 0 233 793 (1987-08-01), None
patent: 0 612 741 (1994-02-01), None
patent: 819690 (1998-01-01), None
patent: 0 899 261 (1999-03-01), None
patent: 1 386 920 (2004-02-01), None
patent: 94/22823 (1994-10-01), None
patent: 95/15312 (1995-06-01), None
patent: 95/17384 (1995-06-01), None
patent: 95/26187 (1995-10-01), None
patent: 97/40012 (1997-10-01), None
patent: 00/44755 (2000-08-01), None
patent: 02/14319 (2002-02-01), None
patent: WO 200214319 (2002-02-01), None
patent: 02/085890 (2002-10-01), None
patent: 03/004493 (2003-01-01), None
Arneric et al., “Cholinergic channel modulators as a novel therapeutic strategy for Alzheimer's disease,” Exp. Opin. Invest. Drugs 5(1):79-100 (1996).
Arneric et al., “Neuronal nicotinic acetylcholine receptors. Novel targets for central nervous system therapeutics,” Psychopharmacology: The Fourth Generation of Progress 95-109 (1995).
Barth et al., “Synthesis of a representative cis/trans pair of 4,5-disubstituted cyclopentenyllithium reagents,” J. Org. Chem. 50:2438-2443 (1985).
Becker et al, “Synthesis of N-BOC-3-azabicyclo[3.3.0]octan-7-one via reductive pauson-khand cyclization and subsequent conversion to a novel diazatricyclic ring system,” Tetrahedron 49(23):5047-5054 (1993).
Beyerman et al., “The synthesis of thiazole-2-and of theiazole-5-carboxylic acid via a halogen-metal exchange reaction,” Trav. Chim. Pays-Bas 73:325 (1954).
Bonjoch et al., “Total synthesis of (±)-deethylibophyllidine: studies of a fischer indolization route and a successful approach via a pummerer rearrangement/thionium ion-mediated indole cyclization,” J. Org. Chem. 61(20):7106-7115 (1996).
Butler et al., A study of the proton nuclear magnetic resonance spectra of aryl and mono- and disubstituted-n-methylazoles, Can. J. Chem. 51:2315-2322 (1973).
Caprathe et al., “Dopamine autoreceptor agonists as ptential antipsychotics. 6-propyl-4,5,5a,6,7,8-hexahydrothiazolo[4,5-ƒ]quinolin-2-amine,” J. Med. Chem. 34(9):2736-2746 (1991).
Carpes et al., “Steroselective synthesis of conformationally restricted analogues of aspartic and glutamic acids from endocyclic enecarbamates,” Tetrahedron Letters 38(11):1869-1872 (1997).
Clayton et al., “A total synthesis of (±) Epibatidine,” Tetrahedron Letters 34:7493-7496 (1993).
Corey et al., “(+)-1(S), 5(R), 8(S)-8-phenyl-2-azabicyclo[3.3.0]octan-8-ol N,O-methylboronate (2) and its enantiomer, chiral chemzymes which serve as catalysts for their own enantioselective synthesis,” Tetrahedron Letters 30(41):5547-5550 (1989).
DeFaria et al., “[2+2] cycloaddition reaction of cyclic enecarbamates and enamides with ketenes, A short and efficient synthesis of geissman-Waiss lactone,” Tetrahedron Letters 34(1):27-30 (1993).
Eastwood, “A versatile synthesis of 4-aryl tetrahydropyridines via palladium mediated Suzuki cross-coupling with cyclic vinyl boronates,” Tetrahedron Letters 41(19):3705-3708 (2000).
Efange et al., “Hydroxylated decahydroquinolines as ligands for the vesicular acetylcholine transporter: synthesis and biological evaluation,” J. Med. Chem. 42(15):2862-2869 (1999).
Evans et al., “The total synthesis of (±)-naphthyridinomycin. I. Preparation of a key tricyclic lactam intermediate,” Tetrahedron Letters 26(16):1907-1910 (1985).
Feldman et al., “Inter- and Intramolecular addition/cyclizations of sulfonamide anions with alkynyliodonium triflates. Synthesis of dihydropyrrole, pyrrole, indole, and tosylenamide heterocycles,” J. Org. Chem. 61(16):5440-5452 (1996).
Gais et al., “Enzyme-catalyzed asymmetric synthesis. Enantioselectivity of pig liver esterase catalyzed hydrolyses of 4-substituted meso cyclopentane 1,2-diesters,” J. Org. Chem. 54:5115-5122 (1989).
Gobeaux et al., “Intramolecular [2+2] cycloadditions of keteniminium salts derived from α-and β-amino acids. A route to azabicyclic detones.” Heterocycles 28(1):29-32 (1989).
Goerdeler et al., “Synthesis and properties of 1,2,4- and 1,3,4-thiodiazole,” Chem. Ber. 89(6):1534-1543 (1956).
Guerry, Helv. Chim. Acta 74:163-177 (1991).
Hand et al., “Teleamination of the imidazo[1,2-a]pyridine system,” J. Org. Chem. 43(14):2900-2906 (1978).
Heathcock et al., “Total Synthesis of (±)-Fawcettimine,” J. Org. Chem. 54:1548-1562 (1989).
Iwamoto et al., “Induction of “petite” mutants of yeast,Saccharomyces cerevisiae, by photodynamic action of acriflavine,” Chem. Pharm. Bull. 33(7):2762-2766 (1985).
Klemm et al., “Chemistry of thienopyridines. IV. Syntheses of 5-substituted thieno [2,3-b]pyridines(1),” J. Heterocycl. Chem. 5:773-778 (1968).
Klemm et al., “Chemistry of thienopyridines. XXXI. A new synthesis of thieno[3,2-b]pyridine and studies on direct substitution into its thiophene ring [1],” J. Heterocycl. Chem. 21:785-790 (1984).
Larock et al., “Palladium (II)-catalyzed cyclization of olefinic tosylamides,” J. Org. Chem. 61(11):3584-3585 (1996).
Lindstrom, “Nicotinic acetylcholine receptors in health and disease,” Molecular Neurobiology 15:193-222 (1997).
Littke et al., “Pd/P(t-Bu)3: A mild and general catalyst for stille reactions of aryl chlorides and aryl bromides,” J. Am. Chem. Soc. 124:6343-6348 (2002).
Lloyd et al., “The potential of subtype selective neuronal nicotinic acetylcholine receptor agonists as therapeutic agents,” Life Sciences 62(17/18):1601-1606 (1998).
Lorvelec et al., “Intramolecular diels-alder reactions involving boryl-3-propenoic acid derivatives,” Tetrahedron Letters 39(29):5185-5188 (1998).
Malpass et al., “Reaction of chlorosulphonyl isocyanate with 1,3-dienes. Control of 1,2- and 1,2-addition pathways and the synthesis of Aza-and Oxa-bicyclic systems,” J. Chem. Soc. Perkin Trans. I 874-884 (1977).
Mathison et al., “synthesis and Stereochemistry of some 8-substituted 2-methyldecahydroisoquinolines,” J. Org. Chem. 39(22):3210-3215 (1974).
McMurry et al., “A method for the regiospecific synthesis of enol triflates by enolate trapping,” Tetrahedron Letters 24(10):979-982 (1983).
Miyajima et al., “Synthesis of biologically active 6-azaprostacyclin derivaties,” Heterocycles 27(3):643-644 (1988).
Morgan et al., “A novel sulfinylation of alkenes by tosyl cyanide with titanium (IV) chloride,” Tetrahedron Letters 40(15):4857-4860 (1999).
Mundy et al., “Reduction of cis-bicyclo[4,3,0]non-3-ene and its 8-substituted heterocyclic analogues,” J. Am. Chem. Soc 102(6):2005-2010 (1980).
Neckers et al., “A greatly improved procedure for ruthenium tetraoxide catalyzed oxidation of organic compounds,” J. Org. Chem. 46(19):3936-3938 (1981).
Ogata et al., “Synthesis and antibacterial activity of new 7-(aminoazabicycloalkanyl)-quinolonecarboxylic acid,” Eur. J. Med. Chem. 26:889-906 (1991).
Ornstein et al., “6-substituted decahydroisoquinoline-3-carboxylic acids as potent and selective conformationally constrained NMDA receptor antagonists,” J. Med. Chem. 35(19):3547-3560 (1992).
Overman et al., “Applications of cationic aza-cope rearrangements for alkoloid synthesis. Stereoselective preparation of cis-3a-aryloctahydroindoles and a new short route to amaryllidacease alkaloids,” J. Am. Chem. Soc. 105(22):6629-6637 (1983).
Overman et al., “Stereocontrolled synthesis of substitutedcis-cyclopenta[b]pyrrolidines,” J. Org.

Affiliated with

Also associated with

Rating

Azabicyclic compounds are central nervous system active agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Azabicyclic compounds are central nervous system active agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Azabicyclic compounds are central nervous system active agents will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3694375